参考文献/References:
[1] Jia H,Kubo T,Akasaka T,et al. Optical coherence tomography guidance in management of acute coronary syndrome caused by plaque erosion[J]. Circ J,2018,82(2):302-308.
[2] Libby P,Pasterkamp G,Crea F,et al. Reassessing the mechanisms of acute coronary syndromes[J]. Circ Res,2019,124(1):150-160.
[3] Jia H,Abtahian F,Aguirre AD,et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography[J]. J Am Coll Cardiol,2013,62(19):1748-1758.
[4] Franck G,Mawson T,Sausen G,et al. Flow perturbation mediates neutrophil recruitment and potentiates endothelial injury via TLR2 in mice: implications for superficial erosion[J]. Circ Res,2017,121(1):31-42.
[5] Quillard T,Araujo HA,Franck G,et al. TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment:implications for superficial erosion[J]. Eur Heart J,2015, 36(22):1394-1404.
[6] Giannopoulos AA,Antoniadis AP,Croce K,et al. Erosion of thin-cap fibroatheroma in an area of low endothelial shear stress:anatomy and local hemodynamic environment dictate outcomes[J]. JACC Cardiovasc Interv,2016,9:e77-e78.
[7] Mullick AE,Tobias PS,Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2[J]. J Clin Invest,2005,115(11):3149-3156.
[8] Chávez-Sánchez L,Garza-Reyes MG,Espinosa-Luna JE,et al. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans[J]. Hum Immunol,2014,75(4):322-329.
[9] Huang B,Park DW,Baek SH. TRIF is a regulator of TLR2-induced foam cell formation[J]. Mol Med Rep,2016,14(4):3329-3335.
[10] Lee GL,Chang YW,Wu JY,et al. TLR2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production[J]. Arterioscler Thromb Vasc Biol,2012,32(11):2751-2760.
[11] Liu X,Ukai T,Yumoto H,et al. Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids[J].Atherosclerosis,2008,196(1):146-154.
[12] Wight TN. A role for proteoglycans in vascular disease[J]. Matrix Biol,2018,71-72:396-420.
[13] Grandoch M,Bollyky PL,Fischer JW. Hyaluronan:a master switch between vascular homeostasis and inflammation[J]. Circ Res,2018,122(10):1341-1343.
[14] Wight TN. Provisional matrix:a role for versican and hyaluronan[J]. Matrix Biol,2017,60-61:38-56.
[15] Jiang D,Liang J,Noble PW. Hyaluronan as an immune regulator in human diseases[J]. Physiol Rev,2011,91(1):221-264.
[16] Pedicino D,Vinci R,Giglio AF,et al. Alterations of hyaluronan metabolism in acute coronary syndrome:implications for plaque erosion[J]. J Am Coll Cardiol,2018,72(13):1490-1503.
[17] D?ring Y,Drechsler M,Soehnlein O,et al. Neutrophils in atherosclerosis:from mice to man[J]. Arterioscler Thromb Vasc Biol,2015,35(2):288-295.
[18] Papayannopoulos V,Metzler KD,Hakkim A,et al. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps[J]. J Cell Biol,2010,191(3):677-691.
[19] D?ring Y,Soehnlein O,Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis[J]. Circ Res,2017,120(4):736-743.
[20] Yipp BG,Petri B,Salina D,et al. Infection-induced netosis is a dynamic process involving neutrophil multitasking in vivo[J]. Nat Med,2012,18(9):1386-1393.
[21] Knight JS,Luo W,O’Dell AA,et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis[J]. Circ Res,2014,114(6):947-956.
[22] Sugiyama S,Kugiyama K,Aikawa M,et al. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression:involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis[J]. Arterioscler Thromb Vasc Biol,2004,24(7):1309-1314.
[23] Gupta AK,Joshi MB,Philippova M,et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death[J]. FEBS Lett,2010, 584(14):3193-3197.
[24] McDonald B,Davis RP,Kim SJ,et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice[J]. Blood,2017,129(10):1357-1367.
[25] Gould TJ,Vu TT,Swystun LL,et al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms[J]. Arterioscler Thromb Vasc Biol,2014,34(9):1977-1984.
[26] Yang X,Li L,Liu J,et al. Extracellular histones induce tissue factor expression in vascular endothelial cells via TLR and activation of NF-κB and AP-1[J]. Thromb Res,2016,137: 211-218.
[27] Martinod K,Wagner DD. Thrombosis:tangled up in nets[J]. Blood,2014,123(18):2768-2776.
[28] Borissoff JI,Joosen IA,Versteylen MO,et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state[J]. Arterioscler Thromb Vasc Biol,2013,33(8):2032-2040.
[29] Stakos DA,Kambas K,Konstantinidis T,et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction[J]. Eur Heart J, 2015,36(22):1405-1414.
[30] Mangold A,Alias S,Scherz T,et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size[J]. Circ Res,2015,116(7):1182-1192.
相似文献/References:
[1]李润土,何泉.光学相干断层成像在急性冠脉综合征介入治疗中的应用[J].心血管病学进展,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
LI Runtu,HE Quan.Application of Optical Coherent Tomography in Interventional Treatment of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(1):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
[2]郑晓雪 季福绥.急性冠脉综合征患者发生急性肾损伤的临床进展[J].心血管病学进展,2019,(5):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
ZHENG Xiaoxue,JI Fusui.Acute Kidney Injury in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(1):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
[3]周小琳 何泉.替格瑞洛在急性冠脉综合征合并慢性肾脏病患者中的应用研究进展[J].心血管病学进展,2019,(5):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
ZHOU Xiaolin,HE Quan.Ticagrelor in Acute Coronary Syndrome with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2019,(1):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
[4]吕俊兴 许海燕.急性冠脉综合征危险评分的研究进展[J].心血管病学进展,2019,(9):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
LU Junxing,XU Haiyan.Risk Scores of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(1):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
[5]段继坤,林志,杨帆,等.斑块侵蚀引起的急性冠脉综合征的研究新进展[J].心血管病学进展,2020,(3):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
DUAN Jikun,LIN Zhi,YANG Fan,et al.Acute Coronary Syndrome Caused by Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(1):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
[6]陈凯磊 胡闻竹 苏冠华.P2Y12抑制剂与癌症风险的相关性研究进展[J].心血管病学进展,2020,(8):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
CHEN Kailei,HU Wenzhu,SU Guanhua.Advances in Studies on the Correlation between P2Y12 Inhibitors and Cancer Risk[J].Advances in Cardiovascular Diseases,2020,(1):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
[7]肖雨尘 赵仙先 马丽萍.急性冠脉综合征患者提前停服替格瑞洛现象的研究进展[J].心血管病学进展,2020,(11):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
Acute Coronary Syndrome.Premature Ticagrelor Discontinuation in Patients with[J].Advances in Cardiovascular Diseases,2020,(1):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[8]冯洁渊 .中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值与急性冠脉综合征的关系研究进展[J].心血管病学进展,2020,(12):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
FENG Jieyuan.The Relationship Between Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio and Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2020,(1):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
[9]魏倩 梁岩.高敏心肌肌钙蛋白在急性冠脉综合征患者中的临床应用进展[J].心血管病学进展,2021,(5):396.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.003]
[10]朱志伦 田乃亮.急性冠脉综合征患者抗血小板降阶治疗方案研究进展[J].心血管病学进展,2021,(6):534.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.014]
ZHU Zhilun,TIAN Nailiang.Advances in De-Escalation of Anti-Platelet Therapy in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2021,(1):534.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.014]